XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 106 filers reported holding XERIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $305,000 | -23.6% | 124,184 | +26.7% | 0.00% | – |
| Q2 2021 | $399,000 | +2.8% | 97,994 | +13.8% | 0.00% | – |
| Q1 2021 | $388,000 | -63.9% | 86,092 | -60.6% | 0.00% | – |
| Q4 2020 | $1,074,000 | +131.5% | 218,244 | +178.9% | 0.00% | – |
| Q3 2020 | $464,000 | +8.7% | 78,246 | -51.3% | 0.00% | – |
| Q2 2020 | $427,000 | +80.2% | 160,532 | +32.2% | 0.00% | – |
| Q1 2020 | $237,000 | +79.5% | 121,459 | +549.5% | 0.00% | – |
| Q4 2019 | $132,000 | -55.3% | 18,700 | -37.6% | 0.00% | – |
| Q3 2019 | $295,000 | +49.7% | 29,987 | +74.2% | 0.00% | – |
| Q2 2019 | $197,000 | -53.9% | 17,213 | -59.6% | 0.00% | – |
| Q1 2019 | $427,000 | -21.1% | 42,574 | +49.4% | 0.00% | – |
| Q2 2018 | $541,000 | – | 28,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|